Litcius/Paper detail

Evidence for trans-synaptic propagation of oligomeric tau in human progressive supranuclear palsy

Robert I. McGeachan, Lois Keavey, Elizabeth Simzer, Ya Yin Chang, Jamie Rose, Maxwell P Spires-Jones, Mollie Gilmore, Kristján Holt, S. Meftah, Natalia Ravingerova, Cristina Scutariu, Lewis W. Taylor, Declan King, Makis Tzioras, Jane Tulloch, Sam A. Booker, Imran Liaquat, Nicole Hindley-Pollock, Bethany Geary, Colin Smith, Paul M. Brennan, Claire S. Durrant, Tara L. Spires‐Jones

2025Nature Neuroscience21 citationsDOIOpen Access PDF

Abstract

In the neurodegenerative disease progressive supranuclear palsy (PSP), tau pathology progresses through the brain in a stereotypical spatiotemporal pattern, and where tau pathology appears, synapses are lost. We tested the hypothesis that pathological tau contributes to synapse loss and may spread through the brain by moving from presynapses to postsynapses. Using postmortem PSP brain samples and a living human brain slice culture model, we observe pathological tau in synaptic pairs and evidence that oligomeric tau can enter live human postsynapses. Proteomics revealed increased clusterin in synapses in PSP, and super-resolution imaging showed clusterin colocalized with tau in synapses in close enough proximity to be binding partners, which may mediate tau spread. Accumulation of tau in synapses correlated with synapse loss, and synaptic engulfment by astrocytes was observed, suggesting that astrocytes contribute to synapse loss. Together, these data indicate that targeting synaptic tau is a promising approach to treat PSP.

Topics & Concepts

Progressive supranuclear palsyNeurosciencePsychologyBiologyMedicinePathologyDiseaseNeuroscience and Neuropharmacology ResearchAlzheimer's disease research and treatmentsParkinson's Disease Mechanisms and Treatments